In the past decades, the doping of ZnO one‐dimensional nanostructures has attracted a great deal of attention due to the variety of possible morphologies, large surface‐to‐volume ratios, simple and ...low cost processing, and excellent physical properties for fabricating high‐performance electronic, magnetic, and optoelectronic devices. This article mainly concentrates on recent advances regarding the doping of ZnO one‐dimensional nanostructures, including a brief overview of the vapor phase transport method and hydrothermal method, as well as the fabrication process for photodetectors. The dopant elements include B, Al, Ga, In, N, P, As, Sb, Ag, Cu, Ti, Na, K, Li, La, C, F, Cl, H, Mg, Mn, S, and Sn. The various dopants which act as acceptors or donors to realize either p‐type or n‐type are discussed. Doping to alter optical properties is also considered. Lastly, the perspectives and future research outlook of doped ZnO nanostructures are summarized.
Recent developments in doping ZnO 1D nanostructured photodetectors are reviewed with a focus on the type of photodetector and the methods of synthesis and fabrication. In this review, the typical fabrication methods and structure–property relationships of these photodetectors are discussed. The photodetector performances of differently doped materials are also summarized and compared.
Contrast associated kidney injury is caused by side effects of iodinated contrast media (ICM), including inflammation. Chronic inflammation among dialysis patient contributes to atherosclerosis, ...which leads to simultaneous conditions of the kidney, brain, and vasculature. Data to investigate the pathologic effects of ICM on cardiovascular complications in dialysis patients are lacking. Dialysis patients who had been exposed to ICM from computed tomography (ICM-CT) were allocated as the ICM-CT cohort (N = 3751), whereas dialysis patients without ICM exposure were randomly allocated as the non-ICM cohort (N = 17,196). Furthermore, 540 pairs were selected for analyses through propensity score-matching in terms of age, sex, comorbidities, dialysis vintage, and index date. During a median follow-up of 10.3 years, ICM-CT cohort had significantly higher risks in the following, compared with non-ICM cohort: all-cause mortality (adjusted hazard ratio aHR, 1.36; 95% confidence interval CI, 1.26-1.47), cardiovascular events (aHR,1.67; 95% CI, 1.39-2.01), acute coronary syndrome (adjusted HR: 2.92; 95% CI, 1.72-4.94), sudden cardiac arrest (aHR, 1.69; 95% CI, 0.90-3.18), heart failure (aHR, 1.71; 95% CI,1.28-2.27), and stroke (aHR, 1.84; 95% CI,1.45-2.35). The proinflammatory ICM is significantly associated with an increased risk of major cardiovascular events in patients on dialysis.
The soft and polar nature of quasi‐2D (PEA)2PbBr4 perovskite, and robust photo‐generated excitons lead exciton‐polaritons and exciton‐polarons as the important phenomena near the band edge for ...application in the lighting aspect. In this work, a convenient methodology is proposed based on the polariton resonant modes in temperature‐dependent (77 K to RT) spectroscopy, and investigate the effect of these quasi‐particles on refractive index dispersion. The large binding energy (≈335 meV) of quasi‐2D excitons is obtained by the reflectance measurements at 77 K. Stable exciton‐polaritons and exciton‐polarons are confirmed by energy dispersions and the observation of self‐trapped exciton‐polaron state, respectively. Furthermore, the large negative thermal‐optic coefficient due to damping effect of exciton‐phonon scattering is observed. The phenomenon is opposite to those observed in conventional semiconductors (e.g., Si, Ge, GaN, AlN, GaAs, AlAs, and ZnO etc.). The observed stable negative thermal‐optic coefficients from 160 K to RT indicate that the quasi‐2D perovskite can be used as a phase compensator for conventional semiconductor materials.
The shrinkage of the energy difference between lower polariton branches (LPs) and upper polariton branches (UPs) proves that oscillator strength decreases when the temperature rises from 77 to 300 K. Therefore, the strong damping effect of exciton‐phonon interactions reduces the oscillator strength when the temperature rises, and further result in the negative thermal‐optic behaviors of quasi‐2D (PEA)2PbBr4 perovskite.
In this work, we propose a system to track the clouds and predict relevant events based on all-sky images. To deal with the nature of variable appearance of clouds, we use clusters of feature points ...to perform tracking. We propose an enhanced clustering algorithm that does not require prior knowledge of number of clusters. The proposed clustering algorithm can successfully separate feature points into groups with reasonable sizes and ranges. In the tracking process, merging and splitting of clouds are handled via checking matched pairs of feature points among different clusters. Afterwards, the tracking information is utilized to predict if the sun will be covered or obscured by clouds within the prediction horizon. Features are extracted from the tracked feature points and a Markov chain model is designed to perform ramp-down event prediction. The obscuration and ramp-down events have an important impact on solar irradiance. The experiments have shown that the proposed system can substantially enhance the accuracy of solar irradiance nowcasting on a challenging dataset.
•Cloud tracking is achieved using clusters of feature points.•An enhanced clustering algorithm is proposed to prevent over-clustering or under-clustering.•Obscuration events are predicted with features of clustering and tracking information.•A graph based model is designed to prediction ramp-down events.•Detection results are applied in irradiance nowcasting frameworks to improve accuracy.
We evaluated the pharmacokinetics, pharmacodynamics, and safety of a single subcutaneous dose of romosozumab 210 mg, a monoclonal antibody against sclerostin, in an open‐label, parallel‐group study ...in participants with severe (stage 4) renal impairment (RI; n = 8) or end‐stage renal disease requiring hemodialysis (ESRD‐RH; n = 8), or healthy participants with normal renal function (n = 8). Compared with the group with normal renal function, the mean romosozumab exposure was 31% and 43% higher as measured by maximum observed serum concentration and area under the concentration‐time curve, respectively, in the severe RI group and similar to those in the ESRD‐RH group. For all 3 groups, the maximum mean percent increase in procollagen type 1 N terminal propeptide and decrease in serum C‐telopeptide levels from baseline were observed on day 15. Changes in procollagen type 1 N terminal propeptide and serum C‐telopeptide were of similar patterns in all 3 groups. The single dose of romosozumab 210 mg was well tolerated. Adverse events (AEs) were reported for 13 patients (7 patients with severe RI and 6 with ESRD‐RH), with no deaths, AEs, or serious AEs leading to withdrawal. The incidence of subjects with postbaseline transient decreases in serum calcium (severe RI, n = 1; ESRD‐RH, n = 5) and increases in intact parathyroid hormone (severe RI, n = 7; ESRD‐RH, n = 7; healthy, n = 3) were greater in severe RI and ESRD‐RH groups than in the healthy group. All reported events of hypocalcemia (severe RI, n = 1; ESRD‐RH, n = 4) were asymptomatic. These results support the use of romosozumab without dose adjustment in patients with severe RI or ESRD‐RH.